Historical record - last NADAC effective date: 3/20/2024
Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.4776 per EA under NDC 69097086585. Its NADAC has been published 384 times since Nov 23, 2016.
FDA first approved this application on Jul 1, 2013.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097086585
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/20/2024
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA204339FDA Approved
7/1/2013
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 384 times since Nov 23, 2016, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4776 per EA |
|---|---|
| All-time high | $1.2127 (Dec 14, 2016) |
| All-time low | $0.4082 (Jan 18, 2023) |
| Median price | $0.7855 |
| Average price | $0.7668 |
| Largest weekly change | +49.6% (Feb 22, 2023) |
| Weeks tracked | 384 |
| Tracking since | Nov 23, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+11.0%
5Y
-18.4%
All
-60.6%
Last surveyed Mar 27, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Cipla USA Inc., is $0.4776 per EA (NDC 69097086585), effective Mar 27, 2024.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 60.6%. It has been tracked across 384 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Nov 23, 2016, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.4082 (Jan 18, 2023) to a high of $1.2127 (Dec 14, 2016), with a median of $0.7855 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 33% below RIZATRIPTAN 5 MG TABLET.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 69097086585) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.